Search results
Jazz Pharmaceuticals’ essential tremor drug falls flat in Phase IIb trial
Clinical Trials Arena via Yahoo Finance· 11 hours agoJazz Pharmaceuticals’ suvecaltamide has failed to meet primary or key secondary endpoints in a Phase...
Jazz Dives — But Key Rival Praxis Surges — On Essential Tremor Drug Failure
Investor's Business Daily· 1 day agoJazz stock toppled Thursday — while shares of rival Praxis Precision Medicines surged — after its ...
Jazz hits dud note as midphase essential tremor test misses endpoint
FierceBiotech· 1 day agoJazz Pharmaceuticals hit a bum note Thursday, reporting the failure of a phase 2b essential tremor...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 10 hours agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Jazz Pharmaceuticals' tremor drug fails in mid-stage study
Reuters via Yahoo News· 1 day agoThe drug, called suvecaltamide, was being tested in adults with essential tremor, a condition that affects the nervous system and causes involuntary and ...
JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals
Zacks via Yahoo Finance· 9 hours agoJAZZ shares are down 5% as it fails to achieve statistical significance on the primary and key...
Diagnosing essential tremor after death helps fami | Newswise
Newswise· 4 days agoJune 18, 2024 – A statistical tool designed to analyze 11 characteristics of postmortem brains...
Gilead Flashes Bullish Sign After HIV Drug Proves 100% Effective
Investor's Business Daily· 1 day agoThe news is a boon for Gilead Sciences (GILD), which already sells its HIV drugs Descovy and Truvada...
Jazz Pharmaceuticals' phase 2b trial for suvecaltamide fails to meet objectives By Investing.com
Investing.com· 1 day agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) disclosed top-line results from its Phase 2b clinical trial...
Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
Zacks via Yahoo Finance· 14 hours agoPraxis Precision Medicines (PRAX) was a big mover last session on higher-than-average trading...
